IMI to hold second quarter fiscal 2004 conference call & webcast

IMI to hold second quarter fiscal 2004 conference call & webcast



TORONTO, Aug. 10  /PRNewswire-FirstCall/ -- IMI International Medical
Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a
conference call and webcast on Thursday, August 12 at 10:30 a.m. (ET) to
discuss the company's second quarter results.

The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking,
Vice President and CFO; and Sarah Borg-Olivier, Director, Communications.
Please dial in five minutes prior to start time:

        Date:                     Thursday, August 12, 2004
        Time:                     10:30 a.m. ET
        Webcast:                  http://www.imimedical.com/ or
http://www.newswire.ca/
        Conference Call Numbers:  [phone] (Toronto)
                                  [phone] (North America)



A webcast will be accessible for three months at http://www.imimedical.com/. A
replay of the call will be available until August 19, 2004 by dialing (416)
640-1917 (Toronto) or [phone] (North America) and entering access code
21070149 followed by the number sign.

About IMI

IMI is a world leader in predictive medicine, dedicated to developing rapid,
non-invasive tests for the early detection of life-threatening diseases. IMI's
cardiovascular products, which are branded as PREVU(x) Coronary Heart Disease
Predictor, will be marketed and distributed worldwide by McNeil Consumer
Healthcare (J&J). The company's cancer tests include ColorectAlert(TM),
LungAlert(TM) and a breast cancer test. IMI's head office is located in
Toronto, and its research and product development facility is at McMaster
University in Hamilton, Ontario. For further information, please visit
http://www.imimedical.com/. 

DATASOURCE: IMI International Medical Innovations Inc.



CONTACT: Sarah Borg-Olivier, Director, Communications, [phone],

Copyright